Science Supporting Biosecurity and Pandemic Preparedness

Pandemics, natural or person-made, have the potential to cause significant, and perhaps unprecedented, harm. We support breakthrough research in the basic science of infectious disease, pathogen detection and identification, and countermeasures. We are especially interested in research that applies to a wide swath of pathogen types. Others at Open Philanthropy support policy and governance efforts to reduce these risks.

Our Work

Blog Post 6/2019

We awarded a five-year grant and made an additional investment in Sherlock Biosciences to support the development of a diagnostic platform to quickly, easily, and inexpensively identify any human virus.

Press 9/2020
from Forbes

Open Philanthropy grantee Dr. David Baker, director of the Institute for Protein Design, received one of the 2021 Breakthrough Prizes in Life Sciences for his work designing unique proteins that can be used for a variety of applications.

Press 8/2020
from The Atlantic

Instead of restructuring daily life around the American way of testing, Open Philanthropy grantee Michael Mina argues, the country should build testing into the American way of life.

placeholder image where no real cover image exists
Grant 7/2020
$415,000

Open Philanthropy recommended a grant to Stanford University to support work led by Professor Jeffrey Glenn to test the efficacy of a universal antiviral drug candidate against all influenza strains.

Press 7/2020
from Forbes

Sherlock Biosciences is partnering with binx health to bring the first point-of-care CRISPR product to market. Open Philanthropy’s support helped establish Sherlock Biosciences.

placeholder image where no real cover image exists
Grant 6/2020
$2,531,000

Open Philanthropy recommended a grant to Stanford University to support work led by Professor Jeffrey Glenn to test an antiviral drug candidate against COVID-19 and a number of other viruses.

placeholder image where no real cover image exists
Grant 5/2020
$130,982

Open Philanthropy recommended a grant to Duke University to support initial studies on the effectiveness of Hsp90 protein inhibitors as host-directed antivirals against the COVID-19 virus.

placeholder image where no real cover image exists
Grant 5/2020
$55,000

Open Philanthropy recommended a grant to the Soroka Medical Center to support a three-month trial study of weekly injections of pegylated interferon lambda proteins as a treatment for COVID-19.

Pages